Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles

Abstract

Tau and amyloid precursor protein (APP) are key proteins in the pathogenesis of sporadic and inherited Alzheimer's disease. Thus, developing ways to inhibit production of these proteins is of great research and therapeutic interest. The selective silencing of mutant alleles, moreover, represents an attractive strategy for treating inherited dementias and other dominantly inherited disorders. Here, using tau and APP as model targets, we describe an efficient method for producing small interfering RNA (siRNA) against essentially any targeted region of a gene. We then use this approach to develop siRNAs that display optimal allele-specific silencing against a well-characterized tau mutation (V337M) and the most widely studied APP mutation (APPsw). The allele-specific RNA duplexes identified by this method then served as templates for constructing short hairpin RNA (shRNA) plasmids that successfully silenced mutant tau or APP alleles. These plasmids should prove useful in experimental and therapeutic studies of Alzheimer's disease. Our results suggest guiding principles for the production of allele-specific siRNA, and the general method described here should facilitate the production of gene-specific siRNAs.

Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer

“…32,33 Recently, a synthetic siRNA sequence against CD was used in normal cell to determine the role of CD in apoptosis. 34 As individual siRNAs targeted to different regions of a transcript display striking differences in efficacy and specificity, [35][36][37] we designed three siRNA sequences against the entire length of pCD mRNA to obtain maximum silencing. All the three siRNA sequences tested were able to downregulate the expression of pCD significantly as expected, use of siRNA-3 in this study exhibited maximum abrogation of pCD (>90%) at both the protein and RNA levels in MDA-MB-231 cells.…”

Suppression of Hepatitis C Virus Replicon by RNA Interference Directed against the NS3 and NS5B Regions of the Viral Genome

“…Because of the effectiveness and specificity in gene silencing, siRNAs and shRNAs are expected to be applicable to gene therapies for hard-to-cure diseases, such as HIV infection (6,22), cancers (43,48) and certain genetic disorders (31). Both siRNAs and shRNAs induce cleavage and degradation of RNA molecules in a sequence-specific manner (11,24,37).…”

Recent Advances in RNA Interference Therapeutics for CNS Diseases

“…Piedrahita et al [126] targeted cyclin-dependent kinase 5, an enzyme required for the phosphorylation of tau using RNAi. Also, studies have targeted tau specifically [127]. cyclindependent kinase 5 suppression reduced phosphorylated tau levels and blocked neurofibrillary tangle formation in transgenic AD mice.…”